AnaptysBio (ANAB) Shares Drop 8% Amid Delaware Breach of Contract Lawsuit Hearing
gurufocus.com · 2026-10-20
On October 20, 2026, AnaptysBio Inc (NASDAQ: ANAB) saw its stock decline 8% as a Delaware court hearing began over a breach of contract lawsuit filed against GS
Read the full story at gurufocus.com →
Is ANAB undervalued? See TickrTrends' fair value analysis →